Annual CFI
-$80.69 M
-$13.30 M-19.73%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual cash flow from investing activities is -$80.69 million, with the most recent change of -$13.30 million (-19.73%) on December 31, 2023.
- During the last 3 years, DNA annual CFI has fallen by -$13.57 million (-20.22%).
- DNA annual CFI is now -20.22% below its all-time high of -$67.12 million, reached on December 31, 2020.
Performance
DNA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$10.20 M
+$16.64 M+62.00%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly cash flow from investing activities is -$10.20 million, with the most recent change of +$16.64 million (+62.00%) on September 30, 2024.
- Over the past year, DNA quarterly CFI has increased by +$36.47 million (+78.15%).
- DNA quarterly CFI is now -134.30% below its all-time high of $29.74 million, reached on December 31, 2022.
Performance
DNA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$95.83 M
-$6.82 M-7.66%
September 30, 2024
Summary
- As of February 8, 2025, DNA TTM cash flow from investing activities is -$95.83 million, with the most recent change of -$6.82 million (-7.66%) on September 30, 2024.
- Over the past year, DNA TTM CFI has dropped by -$15.13 million (-18.75%).
- DNA TTM CFI is now -2139.43% below its all-time high of -$4.28 million, reached on September 30, 2023.
Performance
DNA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
DNA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.7% | +78.2% | -18.8% |
| 3 y3 years | -20.2% | +78.2% | -18.8% |
| 5 y5 years | -8.2% | - | - |
DNA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.7% | at low | -134.3% | +78.2% | -2139.4% | at low |
| 5 y | 5-year | -20.2% | at low | -134.3% | +78.2% | -2139.4% | at low |
| alltime | all time | -20.2% | at low | -134.3% | +78.2% | -2139.4% | at low |
Ginkgo Bioworks Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$10.20 M(-62.0%) | -$95.83 M(+7.7%) |
| Jun 2024 | - | -$26.84 M(+121.6%) | -$89.01 M(+21.3%) |
| Mar 2024 | - | -$12.11 M(-74.1%) | -$73.39 M(-9.1%) |
| Dec 2023 | -$80.69 M(+19.7%) | -$46.67 M(+1280.5%) | -$80.69 M(+1785.8%) |
| Sep 2023 | - | -$3.38 M(-69.9%) | -$4.28 M(-91.0%) |
| Jun 2023 | - | -$11.22 M(-42.2%) | -$47.38 M(-6.8%) |
| Mar 2023 | - | -$19.41 M(-165.3%) | -$50.82 M(-24.6%) |
| Dec 2022 | -$67.39 M | $29.74 M(-164.0%) | -$67.39 M(-27.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$46.49 M(+217.0%) | -$92.91 M(+20.8%) |
| Jun 2022 | - | -$14.66 M(-59.3%) | -$76.93 M(-10.8%) |
| Mar 2022 | - | -$35.98 M(-951.1%) | -$86.20 M(+17.7%) |
| Dec 2021 | -$73.26 M(+9.1%) | $4.23 M(-113.9%) | -$73.26 M(-5.5%) |
| Sep 2021 | - | -$30.51 M(+27.5%) | -$77.48 M(+64.9%) |
| Jun 2021 | - | -$23.93 M(+3.8%) | -$46.98 M(+103.8%) |
| Mar 2021 | - | -$23.05 M | -$23.05 M |
| Dec 2020 | -$67.12 M(-10.0%) | - | - |
| Dec 2019 | -$74.60 M | - | - |
FAQ
- What is Ginkgo Bioworks Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual CFI year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly CFI year-on-year change?
- What is Ginkgo Bioworks Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings TTM CFI year-on-year change?
What is Ginkgo Bioworks Holdings annual cash flow from investing activities?
The current annual CFI of DNA is -$80.69 M
What is the all time high annual CFI for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual cash flow from investing activities is -$67.12 M
What is Ginkgo Bioworks Holdings annual CFI year-on-year change?
Over the past year, DNA annual cash flow from investing activities has changed by -$13.30 M (-19.73%)
What is Ginkgo Bioworks Holdings quarterly cash flow from investing activities?
The current quarterly CFI of DNA is -$10.20 M
What is the all time high quarterly CFI for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly cash flow from investing activities is $29.74 M
What is Ginkgo Bioworks Holdings quarterly CFI year-on-year change?
Over the past year, DNA quarterly cash flow from investing activities has changed by +$36.47 M (+78.15%)
What is Ginkgo Bioworks Holdings TTM cash flow from investing activities?
The current TTM CFI of DNA is -$95.83 M
What is the all time high TTM CFI for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high TTM cash flow from investing activities is -$4.28 M
What is Ginkgo Bioworks Holdings TTM CFI year-on-year change?
Over the past year, DNA TTM cash flow from investing activities has changed by -$15.13 M (-18.75%)